Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
963K
-
Shares change
-
+241K
-
Total reported value, excl. options
-
$1.55M
-
Value change
-
+$453K
-
Number of buys
-
7
-
Number of sells
-
-9
-
Price
-
$1.61
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q1 2023
23 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q1 2023.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 963K shares
of 50M outstanding shares and own 1.93% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (445K shares), Mayo Clinic (182K shares), GEODE CAPITAL MANAGEMENT, LLC (114K shares), SG Americas Securities, LLC (57.2K shares), MAI Capital Management (50K shares), STATE STREET CORP (35.9K shares), DRIVE WEALTH MANAGEMENT, LLC (34.4K shares), NORTHERN TRUST CORP (19.9K shares), Princeton Global Asset Management LLC (16.8K shares), and Tower Research Capital LLC (TRC) (5.22K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.